Close Menu

NEW YORK (360Dx) – The Foundation for Innovative New Diagnostics (FIND) announced today that it has partnered with the nonprofit group Clinical Research Malaysia (CRM) to develop a new strategy for hepatitis C diagnosis.

FIND said it has signed a memorandum of understanding (MOU) to work with CRM to assess the use of rapid diagnostic tests (RDTs) in decentralized primary healthcare facilities in Malaysia. FIND added that it would provide technical assistance to the Malaysian Ministry of Health — which operates CRM — on the project.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Mar
18
Sponsored by
Thermo Fisher Scientific

Viruses mutate as they strive to thrive in response to selective pressures.

Mar
29
Sponsored by
Thermo Fisher Scientific

Global genetic surveillance is vital for understanding the evolution of viral pathogens and monitoring for changes in transmissibility, virulence, disease pathology, and impact on the efficacy of diagnostic tests, therapeutics, and vaccines.